Drug Shortage Report for PRO-AMOX-250
Report ID | 175130 |
Drug Identification Number | 00644331 |
Brand name | PRO-AMOX-250 |
Common or Proper name | AMOX 250 |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | AMOXICILLIN |
Strength(s) | 250MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 100ml |
ATC code | J01CA |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-12-05 |
Actual start date | 2022-11-29 |
Estimated end date | 2023-05-03 |
Actual end date | 2023-05-03 |
Shortage status | Resolved |
Updated date | 2023-05-04 |
Company comments | was under allocation/ était sous allocation -B.O. 2023/02/08 |
Health Canada comments | |
Tier 3 Status | Yes |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v22 | 2023-05-04 | English | Compare |
v21 | 2023-05-03 | French | Compare |
v20 | 2023-05-03 | English | Compare |
v19 | 2023-04-12 | French | Compare |
v18 | 2023-04-12 | English | Compare |
v17 | 2023-03-13 | French | Compare |
v16 | 2023-03-13 | English | Compare |
v15 | 2023-02-08 | French | Compare |
v14 | 2023-02-08 | English | Compare |
v13 | 2023-02-08 | English | Compare |
v12 | 2023-02-08 | French | Compare |
v11 | 2023-02-08 | English | Compare |
v10 | 2022-12-20 | French | Compare |
v9 | 2022-12-20 | English | Compare |
v8 | 2022-12-05 | French | Compare |
v7 | 2022-12-05 | English | Compare |
v6 | 2022-11-30 | English | Compare |
v5 | 2022-11-29 | French | Compare |
v4 | 2022-11-29 | English | Compare |
v3 | 2022-11-18 | English | Compare |